Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,740 | -41,154 | -33,080 | -19,831 | -40,005 |
| Depreciation Amortization | 12,792 | 9,671 | 4,520 | 3,588 | 3,160 |
| Accounts receivable | -21,639 | -5,676 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,538 | 1,053 | N/A | N/A | N/A |
| Other Working Capital | 2,050 | 9,081 | -1,940 | 6,881 | -3,408 |
| Other Operating Activity | 27,291 | 6,764 | -550 | 0 | 0 |
| Operating Cash Flow | $-12,708 | $-20,261 | $-31,050 | $-9,362 | $-40,253 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18,033 | -18,038 | -7,900 | -6,020 | -3,983 |
| Net Acquisitions | N/A | N/A | 0 | -112,594 | 0 |
| Purchase Of Investment | -1,409,021 | -381,609 | N/A | N/A | N/A |
| Sale Of Investment | 1,117,196 | 437,582 | N/A | N/A | N/A |
| Other Investing Activity | 2,399 | -13,701 | -12,490 | -200 | -36,367 |
| Investing Cash Flow | $-307,459 | $24,234 | $-20,390 | $-118,814 | $-40,350 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,120 | 6,795 | N/A | N/A | N/A |
| Debt Repayment | 498,418 | -5,052 | N/A | N/A | N/A |
| Common Stock Issued | 119,787 | 7,646 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 4,160 | 164,791 | 87,050 |
| Financing Cash Flow | $619,325 | $9,389 | $4,160 | $164,791 | $87,050 |
| Exchange Rate Effect | -516 | 48 | 0 | -12 | 14 |
| Beginning Cash Position | 48,017 | 34,607 | 71,450 | 34,851 | 28,390 |
| End Cash Position | 346,659 | 48,017 | 24,160 | 71,454 | 34,851 |
| Net Cash Flow | $298,642 | $13,410 | $-47,280 | $36,603 | $6,461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,708 | -20,261 | -31,050 | -9,362 | -40,253 |
| Capital Expenditure | -18,033 | -18,038 | N/A | N/A | N/A |
| Free Cash Flow | -30,741 | -38,299 | -31,050 | -9,362 | -40,253 |